www.ircp.org Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November 2008 1 Framework to structure the discussion.

Slides:



Advertisements
Similar presentations
Contents: The Consortium Background Goal Objectives Methodology, dissemination strategies and timetable UNIVERSITA CATTOLICA DEL SACRO CUORE MILANO.
Advertisements

European Research Policy: from coordination and cooperation to integration and the ERA Dr. Maria Nedeva MIoIR, MBS. The University of Manchester EULAKS.
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
Brussels Thursday 22 nd March 2007 Nick Kinsella Head of Centre.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
ARQ part II data management Training pack 2: Monitoring drug abuse for policy and practice.
Counter-Terrorism Implementation Task Force (CTITF) Open Briefing to Member States 27 July 2010 Conference Room 2 NLB.
Information needs for effective drug policy in the programme of the CZ PRES Identifying Europe’s information needs for effective drug policy Lisbon /
Model regulations on demand reduction in Europe Bylaw on drug demand reduction.
European Monitoring Centre for Drugs and Drug Addiction Margareta Nilson ISAJE, Helsinki, 1 September 2006.
Dr Fabienne Hariga Senior Adviser UNODC HIV Section, Vienna 27 May 2014 Mandates, missions, roles and responsibilities & relation to health in prisons.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS CARDS 2004, Component 4 Early Warning System Tim Pfeiffer-Gerschel National Focal Point.
A Common Immigration Policy for Europe Principles, actions and tools June 2008.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
Local Strategy for the Integration of the Youth and new employment opportunities Back to the future Connecting the Younger and Older Generation through.
Folie 1 Statistisches Bundesamt STATISTICS ACROSS BORDERS Statistical Co-operation.
Epilepsy in Europe 26th of August Dr. Mat Muijen -Regional Adviser Mental Health.
Overview of SAPS roles and responsibilities and demand reduction Assistant Commissioner Tertius Geldenhuys.
EU-Regional Policy Structural actions 1 LESSONS FROM THE THEMATIC EVALUATION OF THE TERRITORIAL EMPLOYMENT PACTS Veronica Gaffey, DG Regional.
Matching Supply & Demands: Network for Sectoral Approach to Qualifications in Tourism at European LevelGlasgow, 15 – 16 November 2007 METHODOLOGY OF TRANSLATING.
Washington D.C., USA, July 2012www.aids2012.org The HIV/AIDS Civil Society Forum and Think Tank: from policy to action Anna Zakowicz HIV/AIDS Civil.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Prof. Dr. T. Vander Beken.
Enforcement Networks Workshop for Central and Eastern Europe countries on the prosecution of illegal traffic of hazardous and other wastes under the Basel.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) T. Vander Beken – OCTA: outsider’s.
Highlights of Eurodiaconia’s policy messages in 2007.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
2 2. Towards a Pan- European Monitoring System on THB “Pan-EU THB MoSy” Project submitted to the targeted call for proposals: “Prevention And Fight Against.
ONGOING WORK ON DEVELOPING EU-WIDE COMPARABLE STATISTICS ON CRIME, CRIMINAL JUSTICE AND VICTIMISATION Dr Marleen De Smedt EUROSTAT UNECE-UNODC Conference,
Environments of LSOs. Environments is the term used to describe the context in which business is carried out. There are two main environments: Internal:
6 th Regional Statistics Seminar November 1 st, 2013 St. Kitts Marriott, Frigate Bay Beverly Harris 6 th Regional Statistics Seminar November 1 st, 2013.
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Tom Vander Beken – Anticipating.
FP7 /1 EUROPEAN COMMISSION - DG Research Nikos Kastrinos Directorate for Research in Social Sciences, Humanities and Foresight of DG Research, European.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Prof. Dr. T. Vander Beken.
ROMANIA MINISTRY OF EDUCATION, RESEARCH AND INNOVATION National Centre for Development of Vocational Education and Training Implementation Unit of Phare.
Universiteitstraat 4, B-9000 Ghent, 1.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Primary colors R 0 G 39 B 118 R 0 G 161 B 222 R 60 G 138 B 46 R 114 G 199 B 231 R 201 G 221 B 3 R 146 G 212 B 0 Internship at Deloitte Consulting Summer.
A STRATEGY FOR REDUCING DEMAND IN ILLICIT PRODUCTS FROM ENDANGERED SPECIES Background: Why reduce demand? Expert Workshop outcomes Strategy principles.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Tom Vander Beken – How to.
Laboratory on Security Policies and Government of the Territory Valentina Punzo.
Pilot Project on implementation of SEA for regional planning in Ukraine Prof. Dr. Michael Schmidt Dmitry Palekhov Brandenburg University of Technology.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Tom Vander Beken – Assessing.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Prof. Dr. T. Vander Beken.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) The Berabalt project - Ghent, 9 June Setting.
CDA: May CENTRAL DRUG AUTHORITY MANDATE A PRESENTATION TO THE PARLIAMENTARY PORTFOLIO COMMITTEE ON SOCIAL DEVELOPMENT PART 2.
First European conference on drug supply indicators, , Brussels – Feed-back Chloé Carpentier, Laurent Laniel, EMCDDA 33 rd meeting of the.
GSDI 61 Models of National GI Associations GSDI 6 conference September 2002 Budapest.
A network of European National Platforms and Focal Points for Natural Disaster Reduction Common Goals To facilitate and improve the exchange of information.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Prof. Dr. T. Vander Beken.
(S)OCTA Michel QUILLÉ Deputy Director Europol Centre for the Study of Democracy Sofia, Bulgaria – 3 April 2012 Europol Unclassified - Basic Protection.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Prof. Dr. T. Vander Beken.
Universiteitstraat 4, B-9000 Ghent, Belgium T +32 (0) , F +32 (0) Prof. Dr. T. Vander Beken.
Crime Statistics and EU Organised Crime Threat Assessment
The vulnerability of economic markets to crime in 2015
European case studies relating to the administrative approach
What works? Key outcomes from a systematic inventory of 260 meta-evaluations within three knowledge domains: Situational Crime Prevention, Policing and.
Presenter: Beverly Reynolds, DPM, Health Sector Development
Monitoring drug-related crime in Europe: state of play
CLOE: A successful pilot project
A means to an end: criminal analysis and organised crime policy
Organised crime and legal sectors Theory & cases
European Regional and Urban Statistics
15 June 2009 EMCDDA activities ~ Supply Reduction
Assessing organised crime: threat, anticipation and future
Legislative crime proofing - Detection and evaluation of loopholes that offer opportunities for organised crime Prof. Dr. Tom Vander Beken Tackling organised.
The Enter! Recommendation
Presentation transcript:

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November Framework to structure the discussion on the role of the EMCDDA in the monitoring of drug supply in Europe Prof dr. Brice De Ruyver Meeting Scientific Committee EMCDDA November 2008

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November Key Questions  How can the EMCDDA develop drug supply information, collection and analysis?  What data should the EMCDDA collect in the area of supply in order to fulfil its mandate?  Who could be national partners?  What could be topics?  How to link demand reduction and supply reduction information?

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November Starting points 1. The EMCDDA plays a role to map the supply-side. Not the core-business of the EMCDDA, but the task of other organisations. › UNODC, Interpol, Europol: specific areas/ drug production and trafficking linked to organised crime  large-scale and geographically limited.

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November Starting points 2. European drug policy stands for an integrated policy, starting from an epidemiological basis, influencing the demand- and supply-side. Attaining this by: A spectrum of facilities in the fields of prevention, treatment, harm reduction and aftercare= tackling the demand-side. Roughly: law enforcement (criminal, administrative and fiscal law measures)= tackling the supply-side.

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November Starting points 3. Phenomenological: demand- and supply-side interact constantly. › This interaction is very evolutive for specific areas of the drug market (synthetic drugs, retail trade) also concerning the supply, price and quality. › Push on the supply-side creates demand-side (push- factor) The phase in which demand and supply meet on the illegal drug market = very relevant For the actors and domains which influence the demand-side. For the actors who tackle the supply-side.

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November 2008 Starting points It completes the sight upon the integral supply-chain  essential to combat the supply-side in its entirety. Yields a lot of information about: › How the supply-side influences the demand-side. › The used market strategies. › The way the demand-side looks for entrance to the supply-channels and the issues deriving from the latter (drug tourism, drug related crime and drug related nuisance). 6

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November Starting points 4. Gain insight into the nature of the drug market  contextualising essential. This contextualisation relates to: Political factors (national, (EU)-regional, local). Cultural factors (traditions in a multicultural society, the Dutch coffee shops). Economic factors (illegal economy as a push-factor).

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November 2008 Conclusion 1. UN-annual reports (UNODC, CND, INCB) Based upon questionnaires of member states and feeded by law enforcement-dates derived from seizures (= 10% of the real scale). 2. Interpol Is ± reliable concerning the seizures, but some limitations can be stressed (only registered seizures  activity measure of the police and customs + cfr. supra). As worldwide structured organisation, Europol offers a quite fragmental picture. 8

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November 2008 Conclusion 3. Europol Not able to play a prominent role in supply data registering. Fails to produce strategical analysis of the drug traffic from the EU, which should be the case (entrance to Interpol-data, h.o.-network). OCTA (monitoring-based) only gives a fragmental picture. Not the appropriate instrument to concern itself with regional and local drug markets. 4. Customs WCO: worldwide, well-structured  very thorough perception of drug traffics. 9

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November 2008 Conclusion  Conclusion: There is a big gap in the monitoring of regional and local drug markets. 10

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November 2008 Proposal 1. Need for strategical consultation between all international services which collect information about the supply-side. › Aim: to complete the monitoring on the integral supply-chain particulary with qualitative data (due to the impossibility to deliver complete and reliable quantitative data). 11

Universiteitstraat 4, B-9000 Gent, Belgium Meeting Scientific Committee EMCDDA 17 th -18 th November 2008 Proposal 2. For the reasons mentioned before, the EMCDDA can play an important role with regard to the qualitative aspects of the micro-supply- monitoring (regional and local drug markets). The macro-supply is more a task for more law enforcement –oriented organisations. 3. How? The EMCDDA can depend on the appropriate channels (NFP’s, expert meetings, selected issues) for the delivery of data, its contextualisation (cfr supra) and the instigation of strategic policy analysis. 12